MATERNA R-FSH 150IU INJECTION

Materna R-FSH 150IU Injection has the active ingredient Menotrophin. This is an Ovulation Stimulator, which is part of a class of drugs known as gonadotropins. It is a highly pure mixture of follicle-stimulating hormone (FSH) and the luteinizing hormone (LH). These are hormones that males and females naturally produce. They aid the reproductive organs in functioning normally.
Materna R-FSH 150IU Injection can be intended to help treat fertility issues for women who aren’t ovulating, have polycystic ovarian disorder, or have not been able to respond to treatment with a different medicine known as clomiphene. It can also aid in the development of multiple follicles and, consequently, increase fertility for women who are undergoing IVF (in-vitro fertilization) or other forms of assisted conception. It is also used to treat male infertility because of a low sperm count.
Do not take Materna’s R-FSH 150IU injection if you are allergic to menotrophin or any of the other components of this medication. Don’t take this medication if there is an abnormal pituitary gland (a gland at the brain’s bottom that produces hormones, such as growth hormones) or in the hypothalamus (an area located beneath the brain’s surface called the thalamus that regulates the body’s conditions such as blood pressure and temperature) and in your uterus ovaries testicles, breasts or the prostate gland. Before you begin treatment, you’ll be assessed for thyroid issues, hormone levels, and tumors in the hypothalamus and pituitary glands.
Don’t take this medicine if you suffer from ovarian cysts that aren’t caused by PCOD vaginal bleeding and menopausal early signs, or physical issues with the reproductive organs if your womb was removed, or if you are breastfeeding or pregnant. Contact your doctor immediately if you experience any signs, like abdominal pain, swelling or diarrhea, weight gain and breathing difficulties, and a decreased urinary frequency. Inform your doctor if you’ve been diagnosed with liver problems or had a history of blood clotting disease before starting treatment.